U.S. Food and Drug Administration
18 data points extracted from 4 publications by this organisation.
Data points
18
Documents
4
Indicators
16
Regions
1
Publisher type
Government
Bibliography
Documents used
Every publication we have taken a number from, with the date we read it and the link status at that time.
| Document | Type | Published | Retrieved | Link | Data points |
|---|---|---|---|---|---|
| CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024 Licence: See source | Press release | — | 17 Sep 2026 | Reachable | 15 |
| FDA Seeks Public Input to Advance Development of Botanical Drug Products Licence: See source | Press release | — | 17 Sep 2026 | Reachable | 1 |
| Novel Drug Approvals for 2025 Licence: See source | Press release | — | 17 Sep 2026 | Reachable | 1 |
| Novel Drug Approvals for 2024 Licence: See source | Press release | — | 17 Sep 2026 | Reachable | 1 |
Every figure
Data points
Every figure taken from this organisation, grouped by indicator.
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. Credit U.S. Food and Drug Administration as the original publisher; each record page carries its own citation.
U.S. Food and Drug Administration. Retrieved from StatOrigin: https://statorigin.org/sources/us-food-and-drug-administration
Keep exploring
Related
Industries using this source
Last verified 17 September 2026. Link status is rechecked weekly.